RECRUITING
NCT07521930
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Updated: Apr 13, 2026
- RECRUITINGNCT07488338
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Updated: Mar 23, 2026 - RECRUITINGNCT07478172
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Updated: Mar 17, 2026 - RECRUITINGNCT07400198
Gait and Bone Health in SMA
Updated: Mar 18, 2026 - RECRUITINGNCT07332702
Long Read Analysis in Spinal Muscular Atrophy - LOREASI
Updated: Jan 12, 2026 - RECRUITINGNCT07321977
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Updated: Jan 7, 2026 - RECRUITINGNCT07287982
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Updated: Mar 18, 2026 - RECRUITINGNCT07286565
Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening
Updated: Dec 16, 2025 - RECRUITINGNCT07265232
Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).
Updated: Dec 4, 2025 - RECRUITINGNCT07254988
Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders
Updated: Nov 28, 2025 - RECRUITINGNCT07231549
CuidAME: Longitudinal Data Collection From Patients With Spinal Muscular Atrophy in Spain
Updated: Nov 17, 2025 - RECRUITINGNCT07223489
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
Updated: Jan 16, 2026 - RECRUITINGNCT07221669
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Updated: Jan 15, 2026 - RECRUITINGNCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Updated: Apr 8, 2026 - RECRUITINGNCT07070999
Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1
Updated: Mar 2, 2026 - RECRUITINGNCT07047144
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Updated: Mar 25, 2026 - RECRUITINGNCT06978985
Adult SMA Research and Clinical Hub
Updated: May 18, 2025 - RECRUITINGNCT06977269
Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy
Updated: Jun 18, 2025 - RECRUITINGNCT06971094
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
Updated: Jun 5, 2025 - RECRUITINGNCT06955897
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
Updated: Feb 5, 2026
Filter Search
Country*
Sex
Age Group
Observational & Interventional Studies
Expanded Access
Preferred Study Type
Evaluates effect of interventions, e.g. substances
e.g. Patient Registries
Save my filters & notify me of new trials!
Never miss a new SMA Clinical Trial
Register to receive email notifications of new trials matching your profile or updates to saved trials